Similar to the findings from the test set, no markers were found to have the potential to predict survival time of patients with advanced pancreatic cancer (log rank = 1.66 and P > 0.05 for TBIL, log rank = 0.35 and P > 0.05 for DBIL, log rank = 0.24 and P > 0.05 for IBIL, log rank = 0.69 and P > 0.05 for TP, log rank = 0.13 and P > 0.05 for ALB, log rank = 0.81 and P > 0.05 for GLOB, log rank = 1.09 and P > 0.05 for AGR) (Table 2 and Figure 1). The gene discussed is ALB; the disease is familial pancreatic carcinoma.